HKU Scholars Hub: Browsing DSpace

Browsing by Author rp01466

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 151 to 170 of 297 < previous next >

Title	Author(s)	Issue Date	Views
Neoadjuvant Therapy for Neuroendocrine Tumours Proceeding/Conference:Annual conference of the Asia Pacific NeuroEndocrine Tumour Society (APNETS)	Yau, TCC	2014	12
Neoadjuvant therapy with concurrent docetaxel, epirubicin, and cyclophosphamide (TEC) in high-risk HER2-negative breast cancers Journal:Advances in Therapy	Li, B Yau, T Leung, R Kwok, G Tsang, J Cheung, P Wong, TT Suen, D Kwong, A Chiu, JW	2021	19
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial Journal:Journal of Clinical Oncology	Saura, C Oliveira, M Feng, YH Dai, MS Chen, SW Hurvitz, SA Kim, SB Moy, B Delaloge, S Gradishar, W Masuda, N Palacova, M Trudeau, ME Mattson, J Yap, YS V, MF De Laurentiis, M Yeh, YM Chang, HT Yau, T Wildiers, H Haley, B Fagnani, D Lu, YS Crown, J Lin, J Takahashi, M Takano, T Yamaguchi, M Fujii, T Yao, B Bebchuk, J Keyvanjah, K Bryce, R Brufsky, A The NALA Investigators	2020	35
Neuroendocrine Tumor Treatment Development in Asia Proceeding/Conference:The Second HUAXIA Oncology Summit Forum	Yau, TCC	2019	4
Neuroendocrine Tumor Treatment Development in Asia Proceeding/Conference:Asian Neuroendocrine Tumor Expert Meeting (ANEM 2019)	Yau, TCC	2019	11
New Drug Development for Advanced Hepatocellular Carcinoma Proceeding/Conference:Asian Oncology Summit, & Annual Conference of the Organisation for Oncology and Translational Research (OOTR), 2014	Yau, TCC	2014	7
New Perspective in the Targeted Therapy of Advanced Colorectal Cancer Proceeding/Conference:Hong Kong Pathology Forum 2014	Yau, TCC	2014	14
New Perspectives on Managing Progressive mCRC: In the Era of Angiogenesis Proceeding/Conference:Sanofi-Aventis Macau Satellite Symposium, Macau	Yau, TCC	2016	13
A new prognostic classification scheme with treatment guidelines for Asian patients with hepatocellular carcinoma (HCC): the Hong Kong Combined Liver Cancer (HKCLC) classification Proceeding/Conference:Journal of Clinical Oncology	Tang, YF Yao, T Yau, CC Fan, ST Poon, RTP	2011	156
A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: Implication for patient selection in systemic therapy trials Journal:Cancer	Yau, T Tzy, JY Chan, P Ng, K Sheung, TF Poon, RTP	2008	139
Next generation sequencing: profiling gallbladder cancer Proceeding/Conference:Journal of Clinical Oncology	Chiu, JWY Serra, S Kamel-Reid, S Zhang, T McNamara, MG Bedard, PL Hedley, DW Moore, MJ Dhani, NC Shek, TWH Kwong, YL Yau, TCC Doherty, M Knox, JJ	2015	94
Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib Journal:Expert Review of Gastroenterology and Hepatology	Tsang, J Wong, JSL Kwok, GGW Li, BCW Leung, R Chiu, J Cheung, TT Yau, T	2021	12
Nivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis From the CheckMate 040 Study Journal:Journal of Hepatology	Yau, TCC Hsu, C Kim, TY Choo, S Kang, YK Hou, MM Numata, K Yeo, W Chopra, A Ikeda, M Kuromatsu, R Moriguchi, M	2019	272
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial Journal:Lancet	El-Khoueiry, AB Sangro, B Yau, TCC Crocenzi, TS Kudo, M Hsu, C Kim, TY Choo, SP Trojan, J Welling, TH Meyer, T Kang, YK Yeo, W Chopra, A Anderson, J Dela Cruz, C Lang, L Neely, J Tang, H Dastani, HB Melero, I	2017	151
Non-Neutralizing Epitopes Shade Neutralizing Epitopes against Omicron in a Multiple Epitope-Based Vaccine Journal:ACS Infectious Diseases	Gong, HR Hu, YF Li, XC Yau, TCC Zhang, BZ Huang, JD	10-Nov-2022
Novel systemic therapy for hepatocellular carcinoma Journal:Hepatology International	Dong, Y Liu, TH Yau, T Hsu, C	2020	7
Novel Targeted Therapies in the Management of Hepatocellular Carcinoma Proceeding/Conference:Asia-Pacific Gastroenterology Cancer Summit 2013	Yau, TCC	2013	7
The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists? Journal:Acta Ophthalmologica	Ho, WL Wong, HYH Yau, TCC	2013	53
Optimizing mCRC treatment with Regorafnib: Personalised Dosing and AE management Proceeding/Conference:Macau Oncology Association, Invited Lecture	Yau, TCC	2015	13
Optimizing the Sequential Treatment of 3L Metastatic Colorectal Cancer Proceeding/Conference:Bayer Macau Satellite Symposium, Macau	Yau, TCC	2016	17

Showing results 151 to 170 of 297 < previous next >